<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Neurol</journal-id><journal-id journal-id-type="iso-abbrev">Front Neurol</journal-id><journal-id journal-id-type="publisher-id">Front. Neurol.</journal-id><journal-title-group><journal-title>Frontiers in Neurology</journal-title></journal-title-group><issn pub-type="epub">1664-2295</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5844943</article-id><article-id pub-id-type="doi">10.3389/fneur.2018.00078</article-id><article-categories><subj-group subj-group-type="heading"><subject>Neuroscience</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Non-Verbal Cognitive Abilities in Children and Adolescents Affected by Migraine and Tension-Type Headache: An Observational Study Using the Leiter-3</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Margari</surname><given-names>Lucia</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1">*</xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/410666"/></contrib><contrib contrib-type="author"><name><surname>Palumbi</surname><given-names>Roberto</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/525038"/></contrib><contrib contrib-type="author"><name><surname>Lecce</surname><given-names>Paola A.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/500796"/></contrib><contrib contrib-type="author"><name><surname>Craig</surname><given-names>Francesco</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Simone</surname><given-names>Marta</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Margari</surname><given-names>Mariella</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Seccia</surname><given-names>Silvana M. C.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Buttiglione</surname><given-names>Maura</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Basic Medical Sciences, Neuroscience and Sense Organs Department, University of the Study of Bari Aldo Moro, Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari</institution>, <addr-line>Bari</addr-line>, <country>Italy</country></aff><aff id="aff2"><sup>2</sup><institution>Scientific Institute Eugenio Medea (IRCCS) - La Nostra Famiglia</institution>, <addr-line>Brindisi</addr-line>, <country>Italy</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Vincenzo Guidetti, Sapienza Universit&#x000e0; di Roma, Italy</p></fn><fn fn-type="edited-by"><p>Reviewed by: Viktor Farkas, Semmelweis University, Hungary; Yohannes W. Woldeamanuel, Stanford University, United States</p></fn><corresp content-type="corresp" id="cor1">*Correspondence: Lucia Margari, <email>lucia.margari@uniba.it</email></corresp><fn fn-type="other" id="fn001"><p>Specialty section: This article was submitted to Headache Medicine and Facial Pain, a section of the journal Frontiers in Neurology</p></fn></author-notes><pub-date pub-type="epub"><day>05</day><month>3</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>9</volume><elocation-id>78</elocation-id><history><date date-type="received"><day>03</day><month>11</month><year>2017</year></date><date date-type="accepted"><day>05</day><month>2</month><year>2018</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2018 Margari, Palumbi, Lecce, Craig, Simone, Margari, Seccia and Buttiglione.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Margari, Palumbi, Lecce, Craig, Simone, Margari, Seccia and Buttiglione</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Headache is one of the most common neurological disorders in developmental age. Several studies investigated the relationship between headache and emotional/behavioral problems. We studied non-verbal cognitive abilities, including non-verbal memory and attention skills, in order to evaluate the impact of primary headache on these domains. The latest version of the cognitive battery Leiter International Performance Scale &#x02013; Third Edition (Leiter-3), a non-verbal test, was administered to 35 children and adolescents affected by migraine or tension-type headache and to 23 healthy subjects. We found that frequency of attacks and headache disability (evaluated with the Pediatric Migraine Disability Assessment Score Questionnaire) significantly correlate with non-verbal memory and sustained attention skills. However, we found that headache disability has a significant impact on specific cognitive domains related to sustained attention and non-verbal memory skills. The relationship between headache and memory/attention deficits may have an explanation based on a possible common physiopathology ground, including noradrenergic and dopaminergic pathways.</p></abstract><kwd-group><kwd>migraine</kwd><kwd>tension-type headache</kwd><kwd>non-verbal cognitive abilities</kwd><kwd>non-verbal memory</kwd><kwd>attention skills</kwd><kwd>childhood</kwd><kwd>adolescence</kwd></kwd-group><counts><fig-count count="0"/><table-count count="4"/><equation-count count="0"/><ref-count count="28"/><page-count count="6"/><word-count count="4575"/></counts></article-meta></front><body><sec sec-type="introduction" id="S1"><title>Introduction</title><p>Headache has a significant impact on the quality of life of both affected patients and their families. This disorder is very common among children and adolescents (<xref rid="B1" ref-type="bibr">1</xref>). According to a recent review covering epidemiological studies published in the past 25&#x02009;years, the estimated overall mean prevalence of headache among children and adolescents was 54.4% (range: 43.1&#x02013;65.8), and it resulted more common in female than male subjects (<xref rid="B2" ref-type="bibr">2</xref>). Tension-type headache (TTH) and migraines are the most common types of primary headache in pediatric patients (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>). Several studies found an impairment in memory and attention abilities in adult population of migraneurs (<xref rid="B5" ref-type="bibr">5</xref>&#x02013;<xref rid="B7" ref-type="bibr">7</xref>). Instead, the impact of primary headache on cognitive functions is not yet comprehensively studied in children and adolescents; in fact, studies regarding the effect of primary headache on neuropsychological functions showed variable and not consistent results. Villa et al. found deficits in selective and alternate attention in children with migraine (<xref rid="B8" ref-type="bibr">8</xref>). D&#x02019;Andrea et al. described an impairment in both short-term and long-term memory in a sample of migraneurs children, if compared to healthy controls (<xref rid="B9" ref-type="bibr">9</xref>). Another study reported visuo-motor processing speed impairment in both migraneurs children with and without aura (<xref rid="B10" ref-type="bibr">10</xref>). In other studies, lower verbal Intelligence Quotient (IQ) in children with primary headache compared to healthy subjects (<xref rid="B11" ref-type="bibr">11</xref>&#x02013;<xref rid="B13" ref-type="bibr">13</xref>) was reported. Therefore, the aim of this study was the evaluation of any deficit in non-verbal cognitive abilities, including memory and attention abilities, in children and adolescents affected by migraine and TTH. In addition, we investigated the effects of headache clinical features on cognitive functioning in children and adolescents with migraine and TTH.</p></sec><sec sec-type="materials|methods" id="S2"><title>Materials and Methods</title><p>We recruited 35 patients admitted to the University of the Study of Bari &#x0201c;Aldo Moro&#x0201d;, affected by primary headache. Recruitment lasted between February and July 2017. The inclusion criteria for the study were: (a) age between 11 and 18&#x02009;years; (b) diagnosis of primary headache according to the International Classification of Headache Disorders (third edition, beta version) (ICHD-3 beta version). The exclusion criteria were: presence of any anomaly reported at the neurological examination; presence in anamnesis of previous severe head trauma or epilepsy, presence of either major systemic or other neurologic or psychiatric disorders; neuroradiological abnormalities; current or previous use of medications with direct or side effects on central nervous system. All patients were assessed during the interictal period and they did not take anti-migraine medications. The control group included 23 healthy subjects, randomly recruited among children and adolescents attending local state schools. They were matched for age with patients.</p><p>For this study, an ethical review process by the Local Ethics Committee of Azienda Ospedaliero-Universitaria Policlinico di Bari (Italy) was not required, since all the procedures within the study assessment were included in the headache diagnostic protocol of our Child and Adolescence Neuropsychiatry Unit. All the participants were recruited after obtaining a written informed consent by their parents.</p><sec id="S2-1"><title>Assessment</title><p>All patients underwent a general assessment including complete and detailed anamnesis, general and neurological examination, blood tests (blood cells count, liver and renal functions, B12 vitamin, folate and homocysteine dosage), brain magnetic resonance imaging (MRI) examination. Headache assessment included the administration of the Pediatric Migraine Disability Assessment Score Questionnaire (PedMIDAS) (<xref rid="B14" ref-type="bibr">14</xref>) and the administration of a questionnaire created <italic>ad hoc</italic> in order to assess the following characteristics: headache diagnosis, disease duration (expressed in years), and frequency of the attacks (number of events/month).</p><p>PedMIDAS is a questionnaire developed in order to assess migraine disability in pediatric and adolescent patients. It has been tested and validated for ages 4&#x02013;18&#x02009;years, and it is intended to be self-administered by the patients and their parents. It includes five questions: the first two questions are related to the impact of the headache on school performance, while the last three questions focuses on the impact of the headache on home or social activities. The score is a simple composite of the total of five questions. On the basis of this score, the disability grade of the headache is assessed in four levels: no or low disability (grade I; score: 0&#x02013;10); mild disability (grade II; score: 11&#x02013;30); moderate disability (grade III; score: 31&#x02013;50); severe disability (grade IV; score greater than 50). All the participants underwent a cognitive assessment, including the administration of the Leiter International Performance Scale &#x02013; Third Edition (Leiter-3) (<xref rid="B15" ref-type="bibr">15</xref>). The test is completely non-verbal, which means that neither the examiner nor the examinee is required to speak; it covers an expanded age range (3&#x02013;75&#x02009;+&#x02009;years). The Leiter-3 IQ score is not significantly influenced by the examinee&#x02019;s language skills or by educational, social, or family experience. It focuses on fluid intelligence, considered by many the truest measure of a person&#x02019;s innate ability. Leiter-3 includes two distinct batteries: the Cognitive scale and the Attention/Memory scale. The Cognitive Scale is composed by the following subtests: Figure Ground (FG), Classification and Analogies (CA), Sequential Order (SO), Form Completion (FC), and Matching/Repeated patterns (optional subtest); the administration of this scale requires maximum 45&#x02009;min. Attention and Memory scale subtests are as follows: Attention Sustained (AS), Forward Memory (FM), Reverse Memory (RM), Attention Divided (AD), Non-verbal Stroop Congruent (NScc), and Non-verbal Stroop Incongruent (NSic). The non-verbal Stroop effect (NSeff) is the result of the difference between the correct answers of Nsic and NScc. It is an index that allows to evaluate the examinee&#x02019;s ability to keep the attention on a precise stimulus in the presence of a distracter element. The administration requires about 30&#x02009;min. The cognitive scale provides a global non-verbal IQ (nvIQ), obtained by the conversion of the sum of four subtest-scaled scores, preferentially FG, FC, CA, and SO. The Attention and Memory Scale (A/M) provides two composite scores: the first one is the Non-verbal Memory score (nvM), obtained by the sum of subtest-scaled score of FM and RM; the second is the Processing Speed score (PS), derived by the sum of the subtest-scaled score of AS and NSic (number correct). For each subtest, the raw score is the sum of the correct responses marked on the Record Form; raw scores of each subtest are converted into normalized scaled scores, using standard norm tables for the age range that includes the examinee chronological age.</p></sec><sec id="S2-2"><title>Statistical Analysis</title><p>A descriptive analysis of demographic and clinical data was conducted for both patients and control group. Age and gender between the two groups were compared using, respectively, the non-parametric test Mann&#x02013;Whitney U and the Fischer&#x02019;s exact test. The Mann-Whitney U test was also used to analyze the difference of Leiter-3 scores between patients and control groups. In addition, in the patients group, we conducted a correlation analysis in order to evaluate the relationship between the duration of the disease and the frequency of the attacks with Leiter-3 scores. Spearman&#x02019;s rho (r) was used to describe the strength and direction of relationship between these variables.</p><p>Moreover, independent variables (severity, duration, and frequency of headache) were analyzed in the multiple regression analysis in order to evaluate the impact of headache clinical features on cognitive performances (Leiter-3 subtests) in our sample. All the statistical analyses were considered significant with a <italic>p</italic>-value equal or lower than 0.05. For statistical processing, we used the Statistical Package for Social Science version 20.0.</p></sec></sec><sec id="S3"><title>Results</title><p>Demographical data (age and sex distribution) of both groups, diagnosis description, and main characteristics of the headache (migraine with/without aura, TTH; disease duration; frequency of attacks) are reported in Table <xref ref-type="table" rid="T1">1</xref>. Patients and control group were age and sex matched. Leiter-3 scores global comparison between patients and control group are summarized in Table <xref ref-type="table" rid="T2">2</xref>. Nobody showed a global cognitive impairment, non-verbal-IQ mean value in patients group was 97.6&#x02009;&#x000b1;&#x02009;11.3. No statistical significant differences were found in the comparison of Leiter-3 scores between patients and control group. Correlation analysis between disease duration and Leiter-3 scores did not show statistical significant results. Instead, a significant negative correlation was found between the frequency of attacks and nvM (<italic>r</italic>: &#x02212;0.434; <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) and RM (<italic>r</italic>: &#x02212;0.393; <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) (Table <xref ref-type="table" rid="T3">3</xref>). Moreover, we found a significant negative correlation between PedMIDAS scores and some Leiter-3 subtest scores: FG (<italic>r</italic>: &#x02212;0.385; <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05), AS (<italic>r</italic>: &#x02212;0.354; <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05), Nsic (<italic>r</italic>: &#x02212;0.375; <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05), NScc (<italic>r</italic>: &#x02212;0.467; <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05), PS (<italic>r</italic>: &#x02212;0.341; <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) (Table <xref ref-type="table" rid="T3">3</xref>).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Demographic and clinical data of patients and control group.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="center" rowspan="1" colspan="1"/><th valign="top" align="center" colspan="2" rowspan="1">Patients</th><th valign="top" align="center" colspan="2" rowspan="1">Controls</th><th valign="top" align="center" rowspan="1" colspan="1"><italic>p</italic>-Value</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Number</td><td align="center" valign="top" colspan="2" rowspan="1">35</td><td align="center" valign="top" colspan="2" rowspan="1">23</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sex (female)</td><td align="center" valign="top" colspan="2" rowspan="1">15</td><td align="center" valign="top" colspan="2" rowspan="1">9</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;0.05</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sex (male)</td><td align="center" valign="top" colspan="2" rowspan="1">20</td><td align="center" valign="top" colspan="2" rowspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;0.05</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Migraine with aura</td><td align="center" valign="top" colspan="2" rowspan="1">2</td><td align="center" valign="top" colspan="2" rowspan="1">&#x02013;</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Migraine without aura</td><td align="center" valign="top" colspan="2" rowspan="1">24</td><td align="center" valign="top" colspan="2" rowspan="1">&#x02013;</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Tension-type headache</td><td align="center" valign="top" colspan="2" rowspan="1">9</td><td align="center" valign="top" colspan="2" rowspan="1">&#x02013;</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" valign="top" colspan="6" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"><bold>Mean</bold></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>SD</bold></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>Mean</bold></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>SD</bold></td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" colspan="6" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Age (years)</td><td align="center" valign="top" rowspan="1" colspan="1">14.89</td><td align="center" valign="top" rowspan="1" colspan="1">3.2</td><td align="center" valign="top" rowspan="1" colspan="1">14.75</td><td align="center" valign="top" rowspan="1" colspan="1">3.17</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;0.05</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Disease duration</td><td align="center" valign="top" rowspan="1" colspan="1">4.49</td><td align="center" valign="top" rowspan="1" colspan="1">3.1</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Frequency of attacks (number of events/month)</td><td align="center" valign="top" rowspan="1" colspan="1">6.14</td><td align="center" valign="top" rowspan="1" colspan="1">6.4</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;</td></tr></tbody></table></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Global comparison of Leiter-3 scores between patients and control group.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="center" rowspan="2" colspan="1"/><th valign="top" align="center" colspan="2" rowspan="1">Subtest-scaled score, mean (SD)<hr/></th><th valign="top" align="center" rowspan="2" colspan="1"><italic>p</italic>-Value</th></tr><tr><th valign="top" align="center" rowspan="1" colspan="1">Patients (<italic>n</italic>&#x02009;=&#x02009;35)</th><th valign="top" align="center" rowspan="1" colspan="1">Controls (<italic>n</italic>&#x02009;=&#x02009;23)</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">FG</td><td align="center" valign="top" rowspan="1" colspan="1">9.37 (3.0)</td><td align="center" valign="top" rowspan="1" colspan="1">8.43 (3.0)</td><td align="center" valign="top" rowspan="1" colspan="1">0.260</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FC</td><td align="center" valign="top" rowspan="1" colspan="1">9.20 (2.7)</td><td align="center" valign="top" rowspan="1" colspan="1">9.09 (2.3)</td><td align="center" valign="top" rowspan="1" colspan="1">0.860</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CA</td><td align="center" valign="top" rowspan="1" colspan="1">10.09 (2.7)</td><td align="center" valign="top" rowspan="1" colspan="1">9.70 (3.1)</td><td align="center" valign="top" rowspan="1" colspan="1">0.873</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SO</td><td align="center" valign="top" rowspan="1" colspan="1">9.97 (2.6)</td><td align="center" valign="top" rowspan="1" colspan="1">10.22 (2.1)</td><td align="center" valign="top" rowspan="1" colspan="1">0.619</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">nvIQ</td><td align="center" valign="top" rowspan="1" colspan="1">98.03 (13.4)</td><td align="center" valign="top" rowspan="1" colspan="1">95.83 (10.5)</td><td align="center" valign="top" rowspan="1" colspan="1">0.679</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">AS</td><td align="center" valign="top" rowspan="1" colspan="1">8.97 (2.4)</td><td align="center" valign="top" rowspan="1" colspan="1">10.00 (3.0)</td><td align="center" valign="top" rowspan="1" colspan="1">0.331</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FM</td><td align="center" valign="top" rowspan="1" colspan="1">9.29 (3.1)</td><td align="center" valign="top" rowspan="1" colspan="1">9.39 (2.4)</td><td align="center" valign="top" rowspan="1" colspan="1">0.968</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">RM</td><td align="center" valign="top" rowspan="1" colspan="1">9.06 (2.7)</td><td align="center" valign="top" rowspan="1" colspan="1">9.36 (2.3)</td><td align="center" valign="top" rowspan="1" colspan="1">0.591</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Nsic</td><td align="center" valign="top" rowspan="1" colspan="1">10.31 (3.1)</td><td align="center" valign="top" rowspan="1" colspan="1">9.87 (2.1)</td><td align="center" valign="top" rowspan="1" colspan="1">0.592</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NScc</td><td align="center" valign="top" rowspan="1" colspan="1">9.71 (3.2)</td><td align="center" valign="top" rowspan="1" colspan="1">9.39 (3.0)</td><td align="center" valign="top" rowspan="1" colspan="1">0.829</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NSeff</td><td align="center" valign="top" rowspan="1" colspan="1">10.00 (3.2)</td><td align="center" valign="top" rowspan="1" colspan="1">8.78 (3.3)</td><td align="center" valign="top" rowspan="1" colspan="1">0.135</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">nvM</td><td align="center" valign="top" rowspan="1" colspan="1">94.06 (17.6)</td><td align="center" valign="top" rowspan="1" colspan="1">93.52 (21.7)</td><td align="center" valign="top" rowspan="1" colspan="1">0.644</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PS</td><td align="center" valign="top" rowspan="1" colspan="1">96.23 (16.3)</td><td align="center" valign="top" rowspan="1" colspan="1">100.17 (14.4)</td><td align="center" valign="top" rowspan="1" colspan="1">0.435</td></tr></tbody></table><table-wrap-foot><p><italic>FG, Figure Ground; FC, Form Completion; CA, Classification/Analogies; SO, Sequential Order; nvIQ, non-verbal Intelligence Quotient; AS, Attention Sustained; FM, Forward Memory; RM, Reverse Memory; Nsic, Non-verbal Stroop Incongruent; NScc, Non-verbal Stroop Congruent; NSeff, Non-verbal Stroop Effect; nvM, non-verbal Memory; PS, Processing Speed</italic>.</p></table-wrap-foot></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Correlation analysis between Leiter-3 scores and frequency of the attacks, duration of disease and PedMIDAS scores in patients group.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="center" rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1">FG</th><th valign="top" align="center" rowspan="1" colspan="1">FC</th><th valign="top" align="center" rowspan="1" colspan="1">CA</th><th valign="top" align="center" rowspan="1" colspan="1">SO</th><th valign="top" align="center" rowspan="1" colspan="1">nvIQ</th><th valign="top" align="center" rowspan="1" colspan="1">AS</th><th valign="top" align="center" rowspan="1" colspan="1">FM</th><th valign="top" align="center" rowspan="1" colspan="1">RM</th><th valign="top" align="center" rowspan="1" colspan="1">Nsic</th><th valign="top" align="center" rowspan="1" colspan="1">NScc</th><th valign="top" align="center" rowspan="1" colspan="1">NSeff</th><th valign="top" align="center" rowspan="1" colspan="1">nvM</th><th valign="top" align="center" rowspan="1" colspan="1">PS</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="2" colspan="1">Frequency of attacks (no of events/month)</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>r</italic></td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.253</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.065</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.154</td><td align="center" valign="top" rowspan="1" colspan="1">0.029</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.166</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.243</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.317</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.393</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.181</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.118</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.036</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.434</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.253</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic>p</italic></td><td align="center" valign="top" rowspan="1" colspan="1">0.142</td><td align="center" valign="top" rowspan="1" colspan="1">0.712</td><td align="center" valign="top" rowspan="1" colspan="1">0.378</td><td align="center" valign="top" rowspan="1" colspan="1">0.869</td><td align="center" valign="top" rowspan="1" colspan="1">0.341</td><td align="center" valign="top" rowspan="1" colspan="1">0.160</td><td align="center" valign="top" rowspan="1" colspan="1">0.063</td><td align="center" valign="top" rowspan="1" colspan="1">0.020<xref ref-type="table-fn" rid="tfn1">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.299</td><td align="center" valign="top" rowspan="1" colspan="1">0.500</td><td align="center" valign="top" rowspan="1" colspan="1">0.839</td><td align="center" valign="top" rowspan="1" colspan="1">0.009<xref ref-type="table-fn" rid="tfn1">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.142</td></tr><tr><td align="left" valign="top" colspan="15" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="2" colspan="1">Duration of disease</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>r</italic></td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.121</td><td align="center" valign="top" rowspan="1" colspan="1">0.162</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.150</td><td align="center" valign="top" rowspan="1" colspan="1">0.251</td><td align="center" valign="top" rowspan="1" colspan="1">0.008</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.161</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.119</td><td align="center" valign="top" rowspan="1" colspan="1">0.004</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.234</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.191</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.138</td><td align="center" valign="top" rowspan="1" colspan="1">0.015</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.110</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic>p</italic></td><td align="center" valign="top" rowspan="1" colspan="1">0.487</td><td align="center" valign="top" rowspan="1" colspan="1">0.354</td><td align="center" valign="top" rowspan="1" colspan="1">0.391</td><td align="center" valign="top" rowspan="1" colspan="1">0.146</td><td align="center" valign="top" rowspan="1" colspan="1">0.964</td><td align="center" valign="top" rowspan="1" colspan="1">0.355</td><td align="center" valign="top" rowspan="1" colspan="1">0.497</td><td align="center" valign="top" rowspan="1" colspan="1">0.982</td><td align="center" valign="top" rowspan="1" colspan="1">0.176</td><td align="center" valign="top" rowspan="1" colspan="1">0.272</td><td align="center" valign="top" rowspan="1" colspan="1">0.428</td><td align="center" valign="top" rowspan="1" colspan="1">0.931</td><td align="center" valign="top" rowspan="1" colspan="1">0.530</td></tr><tr><td align="left" valign="top" colspan="15" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="2" colspan="1">PedMIDAS scores</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>r</italic></td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.385</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.095</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.162</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.158</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.260</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.354</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.288</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.260</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.375</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.467</td><td align="center" valign="top" rowspan="1" colspan="1">0.121</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.286</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.341</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic>p</italic></td><td align="center" valign="top" rowspan="1" colspan="1">0.023<xref ref-type="table-fn" rid="tfn1">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.589</td><td align="center" valign="top" rowspan="1" colspan="1">0.352</td><td align="center" valign="top" rowspan="1" colspan="1">0.366</td><td align="center" valign="top" rowspan="1" colspan="1">0.131</td><td align="center" valign="top" rowspan="1" colspan="1">0.037<xref ref-type="table-fn" rid="tfn1">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.093</td><td align="center" valign="top" rowspan="1" colspan="1">0.131</td><td align="center" valign="top" rowspan="1" colspan="1">0.027<xref ref-type="table-fn" rid="tfn1">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.005<xref ref-type="table-fn" rid="tfn1">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.488</td><td align="center" valign="top" rowspan="1" colspan="1">0.095</td><td align="center" valign="top" rowspan="1" colspan="1">0.045<xref ref-type="table-fn" rid="tfn1">*</xref></td></tr></tbody></table><table-wrap-foot><p>FG, Figure Ground; FC, Form Completion; CA, Classification/Analogies; SO, Sequential Order; nvIQ, non-verbal Intelligence Quotient; AS, Attention Sustained; FM, Forward Memory; RM, Reverse Memory; Nsic, Non-verbal Stroop Incongruent; NScc, Non-verbal Stroop Congruent; NSeff, Non-verbal Stroop Effect; nvM, non-verbal Memory; PS, Processing Speed.</p><fn id="tfn1"><p>*<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></fn></table-wrap-foot></table-wrap><p>The multivariate regression analysis (Table <xref ref-type="table" rid="T4">4</xref>) showed that only PedMIDAS score was significantly associated with FG (95% CI; <italic>p</italic>&#x02009;=&#x02009;0.04), FM (95% CI; <italic>p</italic>&#x02009;=&#x02009;0.04), NSeff (95% CI; <italic>p</italic>&#x02009;=&#x02009;0.01) scores; on the contrary, we did not found a significant association of PedMIDAS score on FC (95% CI; <italic>p</italic>&#x02009;=&#x02009;0.5), CA (95% CI; <italic>p</italic>&#x02009;=&#x02009;0.51), SO (95% CI; <italic>p</italic>&#x02009;=&#x02009;0.67), nvIQ (95% CI; <italic>p</italic>&#x02009;=&#x02009;0.19), AS (95% CI; <italic>p</italic>&#x02009;=&#x02009;0.13), RM (95% CI; <italic>p</italic>&#x02009;=&#x02009;0.22), NSic (95% CI; <italic>p</italic>&#x02009;=&#x02009;0.07), NScc (95% CI; <italic>p</italic>&#x02009;=&#x02009;0.06), PS (95% CI; <italic>p</italic>&#x02009;=&#x02009;0.14), and nvM (95% CI; <italic>p</italic>&#x02009;=&#x02009;0.24). We did not found a significant association of frequency of attacks and disease duration with Leiter-3 subtests scores (Table <xref ref-type="table" rid="T4">4</xref>).</p><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Multivariate regression analysis between PedMIDAS scores, disease duration and frequency of attacks and Leiter-3 subtests scores.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="center" colspan="5" rowspan="1"/><th valign="top" align="center" colspan="2" rowspan="1">95% CI<hr/></th></tr><tr><th valign="top" align="center" colspan="2" rowspan="1"/><th valign="top" align="center" rowspan="1" colspan="1"><italic>B</italic></th><th valign="top" align="center" rowspan="1" colspan="1"><italic>t</italic></th><th valign="top" align="center" rowspan="1" colspan="1"><italic>p</italic>-Value</th><th valign="top" align="center" rowspan="1" colspan="1">Inf</th><th valign="top" align="center" rowspan="1" colspan="1">sup</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">FG</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PedMIDAS</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.91</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;2.13</td><td align="center" valign="top" rowspan="1" colspan="1">0.04<xref ref-type="table-fn" rid="tfn2">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.78</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.04</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Disease duration</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.09</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.54</td><td align="center" valign="top" rowspan="1" colspan="1">0.60</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.42</td><td align="center" valign="top" rowspan="1" colspan="1">0.24</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Frequency of attacks</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.07</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.96</td><td align="center" valign="top" rowspan="1" colspan="1">0.34</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.23</td><td align="center" valign="top" rowspan="1" colspan="1">0.08</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">FC</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PedMIDAS</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.28</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.66</td><td align="center" valign="top" rowspan="1" colspan="1">0.50</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.13</td><td align="center" valign="top" rowspan="1" colspan="1">0.57</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Disease duration</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">0.15</td><td align="center" valign="top" rowspan="1" colspan="1">0.93</td><td align="center" valign="top" rowspan="1" colspan="1">0.36</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.18</td><td align="center" valign="top" rowspan="1" colspan="1">0.47</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Frequency of attacks</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.06</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.74</td><td align="center" valign="top" rowspan="1" colspan="1">0.47</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.21</td><td align="center" valign="top" rowspan="1" colspan="1">0.10</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">CA</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PedMIDAS</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.28</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.67</td><td align="center" valign="top" rowspan="1" colspan="1">0.51</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.13</td><td align="center" valign="top" rowspan="1" colspan="1">0.57</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Disease duration</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">0.15</td><td align="center" valign="top" rowspan="1" colspan="1">0.93</td><td align="center" valign="top" rowspan="1" colspan="1">0.36</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.18</td><td align="center" valign="top" rowspan="1" colspan="1">0.47</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Frequency of attacks</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.06</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.74</td><td align="center" valign="top" rowspan="1" colspan="1">0.47</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.21</td><td align="center" valign="top" rowspan="1" colspan="1">0.10</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">SO</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PedMIDAS</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.18</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.43</td><td align="center" valign="top" rowspan="1" colspan="1">0.67</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.04</td><td align="center" valign="top" rowspan="1" colspan="1">0.68</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Disease duration</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.14</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.85</td><td align="center" valign="top" rowspan="1" colspan="1">0.40</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.46</td><td align="center" valign="top" rowspan="1" colspan="1">0.19</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Frequency of attacks</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.03</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.43</td><td align="center" valign="top" rowspan="1" colspan="1">0.67</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.19</td><td align="center" valign="top" rowspan="1" colspan="1">0.12</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">nvIQ</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PedMIDAS</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.52</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.35</td><td align="center" valign="top" rowspan="1" colspan="1">0.19</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.31</td><td align="center" valign="top" rowspan="1" colspan="1">0.27</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Disease duration</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">0.24</td><td align="center" valign="top" rowspan="1" colspan="1">1.64</td><td align="center" valign="top" rowspan="1" colspan="1">0.11</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.06</td><td align="center" valign="top" rowspan="1" colspan="1">0.54</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Frequency of attacks</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">0.05</td><td align="center" valign="top" rowspan="1" colspan="1">0.78</td><td align="center" valign="top" rowspan="1" colspan="1">0.44</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.09</td><td align="center" valign="top" rowspan="1" colspan="1">0.20</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">AS</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PedMIDAS</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;3.16</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.57</td><td align="center" valign="top" rowspan="1" colspan="1">0.13</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;7.27</td><td align="center" valign="top" rowspan="1" colspan="1">0.95</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Disease duration</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">0.27</td><td align="center" valign="top" rowspan="1" colspan="1">0.36</td><td align="center" valign="top" rowspan="1" colspan="1">0.72</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.29</td><td align="center" valign="top" rowspan="1" colspan="1">1.83</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Frequency of attacks</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.16</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.44</td><td align="center" valign="top" rowspan="1" colspan="1">0.66</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.90</td><td align="center" valign="top" rowspan="1" colspan="1">0.58</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">FM</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PedMIDAS</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.73</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;2.11</td><td align="center" valign="top" rowspan="1" colspan="1">0.04<xref ref-type="table-fn" rid="tfn2">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.43</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.03</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Disease duration</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.05</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.38</td><td align="center" valign="top" rowspan="1" colspan="1">0.70</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.32</td><td align="center" valign="top" rowspan="1" colspan="1">0.22</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Frequency of attacks</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.06</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.92</td><td align="center" valign="top" rowspan="1" colspan="1">0.37</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.18</td><td align="center" valign="top" rowspan="1" colspan="1">0.07</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">RM</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PedMIDAS</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.59</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.27</td><td align="center" valign="top" rowspan="1" colspan="1">0.22</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.53</td><td align="center" valign="top" rowspan="1" colspan="1">0.36</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Disease duration</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.20</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.12</td><td align="center" valign="top" rowspan="1" colspan="1">0.27</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.56</td><td align="center" valign="top" rowspan="1" colspan="1">0.16</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Frequency of attacks</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.07</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.90</td><td align="center" valign="top" rowspan="1" colspan="1">0.38</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.24</td><td align="center" valign="top" rowspan="1" colspan="1">0.10</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">Nsic</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PedMIDAS</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.73</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.89</td><td align="center" valign="top" rowspan="1" colspan="1">0.07</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.52</td><td align="center" valign="top" rowspan="1" colspan="1">0.06</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Disease duration</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">0.01</td><td align="center" valign="top" rowspan="1" colspan="1">0.05</td><td align="center" valign="top" rowspan="1" colspan="1">0.96</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.29</td><td align="center" valign="top" rowspan="1" colspan="1">0.31</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Frequency of attacks</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.10</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.44</td><td align="center" valign="top" rowspan="1" colspan="1">0.16</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.24</td><td align="center" valign="top" rowspan="1" colspan="1">0.04</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">NScc</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PedMIDAS</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.89</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.95</td><td align="center" valign="top" rowspan="1" colspan="1">0.06</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.82</td><td align="center" valign="top" rowspan="1" colspan="1">0.04</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Disease duration</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.11</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.61</td><td align="center" valign="top" rowspan="1" colspan="1">0.55</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.46</td><td align="center" valign="top" rowspan="1" colspan="1">0.25</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Frequency of attacks</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.04</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.45</td><td align="center" valign="top" rowspan="1" colspan="1">0.66</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.20</td><td align="center" valign="top" rowspan="1" colspan="1">0.13</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">Nseff</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PedMIDAS</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.17</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;2.74</td><td align="center" valign="top" rowspan="1" colspan="1">0.01<xref ref-type="table-fn" rid="tfn2">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;2.04</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.30</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Disease duration</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.09</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.55</td><td align="center" valign="top" rowspan="1" colspan="1">0.59</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.42</td><td align="center" valign="top" rowspan="1" colspan="1">0.24</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Frequency of attacks</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">0.15</td><td align="center" valign="top" rowspan="1" colspan="1">2.00</td><td align="center" valign="top" rowspan="1" colspan="1">0.05</td><td align="center" valign="top" rowspan="1" colspan="1">0.00</td><td align="center" valign="top" rowspan="1" colspan="1">0.31</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">PS</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PedMIDAS</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;3.81</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.50</td><td align="center" valign="top" rowspan="1" colspan="1">0.14</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;9.00</td><td align="center" valign="top" rowspan="1" colspan="1">1.38</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Disease duration</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.32</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.33</td><td align="center" valign="top" rowspan="1" colspan="1">0.74</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;2.29</td><td align="center" valign="top" rowspan="1" colspan="1">1.65</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Frequency of attacks</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.78</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.71</td><td align="center" valign="top" rowspan="1" colspan="1">0.10</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.71</td><td align="center" valign="top" rowspan="1" colspan="1">0.15</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">nvM</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PedMIDAS</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">0.57</td><td align="center" valign="top" rowspan="1" colspan="1">1.20</td><td align="center" valign="top" rowspan="1" colspan="1">0.24</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.40</td><td align="center" valign="top" rowspan="1" colspan="1">1.54</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Disease duration</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.29</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.58</td><td align="center" valign="top" rowspan="1" colspan="1">0.12</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.65</td><td align="center" valign="top" rowspan="1" colspan="1">0.08</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Frequency of attacks</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.02</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.24</td><td align="center" valign="top" rowspan="1" colspan="1">0.81</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.19</td><td align="center" valign="top" rowspan="1" colspan="1">0.15</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><p><italic>FG, Figure Ground; FC, Form Completion; CA, Classification/Analogies; SO, Sequential Order; nvIQ, non-verbal Intelligence Quotient; AS, Attention Sustained; FM, Forward Memory; RM, Reverse Memory; Nsic, Non-verbal Stroop Incongruent; NScc, Non-verbal Stroop Congruent; NSeff, Non-verbal Stroop Effect; nvM, non-verbal Memory; PS, Processing Speed; CI, Confidence Interval</italic>.</p><fn id="tfn2"><p><italic>*p&#x02009;&#x0003c;&#x02009;0.05</italic>.</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion" id="S4"><title>Discussion</title><p>The impact of primary headache on the cognitive functions in the pediatric population is not yet comprehensively understood. For the first time, in 1989, D&#x02019;Andrea et al. described a specific impairment in short- and long-term memory in a sample of 20 migraneurs children using &#x0201c;The logical memory test&#x0201d; and the &#x0201c;Rey memory test&#x0201d; (<xref rid="B9" ref-type="bibr">9</xref>). On the other hand, Haverkamp et al. did not find significant differences comparing processing speed performances of migraneurs with healthy controls (<xref rid="B16" ref-type="bibr">16</xref>). Later, in an Italian cross-sectional study, Parisi et al. administered the Wechsler Intelligence Scale for Children-Revised to 82 children affected by migraine without aura and TTH (<xref rid="B11" ref-type="bibr">11</xref>). They found significant worse performances in terms of total IQ (TIQ) and verbal skills, comparing the subgroup of patients with healthy controls. Moreover, they found a negative correlation between TIQ, verbal IQ, and performance IQ and the frequency of the attacks. Lastly, they found a significant correlation between the age of headache onset and the TIQ. Therefore, these results suggested a possible relationship between the severity of the headache and the global cognitive abilities. In addition, Esposito et al. found lower verbal performance in patients with TTH if compared to migraneurs patients and healthy controls, using the Wechsler Intelligence Scale for Children-third edition (WISC-III) (<xref rid="B13" ref-type="bibr">13</xref>). In these previous studies, the researchers investigated cognitive competences using protocols requiring verbal skills. We studied non-verbal cognitive abilities, such as fluid intelligence, non-verbal memory, attention, in children and adolescents affected by primary headache, using the latest version of the cognitive battery Leiter-3 (<xref rid="B15" ref-type="bibr">15</xref>). This is a non-verbal test allowing the evaluation of those skills, without significant bias determined by the cultural of individual, educational, and social factors. Differently from the previous edition, the Leiter-3 cognitive battery provides a non-verbal IQ with just four subtests. The internal structure of this test allows to study non-verbal attention and memory skills separately from other cognitive aspects. In accordance to previous studies (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B16" ref-type="bibr">16</xref>), primary headache has not an impact on global non-verbal cognitive abilities. We found that frequency of attacks and headache disability (evaluated with the PedMIDAS) significantly correlate with non-verbal memory (nvM and RM) and sustained attention skills (FG, AS, Nsic, NScc, PS). However, we found that headache disability has a significant impact on specific cognitive domains related to both non-verbal memory and sustained attention skills (FG, FM, NSeff). Non-verbal Memory is obtained by the sum of RM and FM subtest-scaled scores. RM subtest measures the memory span of figures backwards. Reverse memory is a complex mental activity that requires storing and manipulating information; it implies a good working memory, not required for the forward memory subtest. FG subtest is a task of simple visual interference, similar to a visual recognition but with distracters and enlargements. In this subtest, the performance is related to the individual cognitive flexibility (i.e., his ability to shift attention), since he needs to shift attention from a well-defined figure to a complex background, modifying in a sense his perceptual set (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B18" ref-type="bibr">18</xref>). AS subtest requires attention and selectivity skills; the examinee is asked to perform a simple repetitive task that does not require any new cognitive processing. An individual who shows deficiency in this subtest may have an underlying attentive problem. PS score depends on the performance in AS and Nsic subtests; hence, it is considered a measure of attention, working memory, and inhibitory skills of the examinee. Therefore, our results suggest that a higher headache disability may have an impact on non-verbal memory, attention sustained. Le Pira et al. found both short-term and long-term memory defects in 30 adult migraneurs, when compared with 14 healthy subjects. The authors suggested that this impairment was probably related to defective learning strategies and memory recall mechanisms (<xref rid="B6" ref-type="bibr">6</xref>). In 2002, Calandre et al. revealed disturbances in memory, attention, and visuo-motor speed processing among adult migraneurs experiencing higher frequency of attacks. Moreover, they found a potential relationship between brain perfusion abnormalities and some cognitive deficits, such as visual and verbal memory skills (<xref rid="B5" ref-type="bibr">5</xref>). Later, Villa et al. administered a visual attention assessment to 30 migraineurs children and then they compared their performance with a control group. For this assessment, the authors used three tests: Trail Making Test (TMT) A/B, Letter Cancelation Test and the Brazilian computerized Visual Attention Test. The migraine group showed worse results in selective and alternate attention tasks, when compared with the control group (<xref rid="B8" ref-type="bibr">8</xref>). Later, Moutran et al. compared 30 children migraneurs with 30 healthy children; both groups underwent a cognitive assessment using WISC-III. All the participants had a normal cognitive performance, but children with migraine and TTH showed worse performance in attention, memory, and speed processing information (<xref rid="B12" ref-type="bibr">12</xref>). The relationship between headache and memory/attention deficits may have an explanation based on a possible common physiopathology ground. These cognitive functions involve several brain regions, both cortical and subcortical areas (<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B11" ref-type="bibr">11</xref>). Moreover, some neurotransmitters, such as dopamine and noradrenaline, mediate an important role in attention, working memory, and learning tasks (<xref rid="B19" ref-type="bibr">19</xref>&#x02013;<xref rid="B21" ref-type="bibr">21</xref>). Both dopaminergic and noradrenergic pathways are also involved in migraine pathogenesis (<xref rid="B22" ref-type="bibr">22</xref>&#x02013;<xref rid="B25" ref-type="bibr">25</xref>). In fact, noradrenaline modulates hyperexcitability of the trigeminovascular system; low levels of this mediator predispose migraneurs to more intense and long lasting cardiovascular symptoms, such as tachycardia and high pressure levels, associated with the migraine attack (<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B26" ref-type="bibr">26</xref>). On the other hand, normal levels of noradrenaline promote adequate levels of selective, alternate and also sustained attention, mediating cortex, and subcortical pathways via-&#x003b1;2 noradrenergic receptors (<xref rid="B27" ref-type="bibr">27</xref>). Dopaminergic connections modulate not only trigeminovascular system excitability but also cognitive functions involving working memory and attention skills (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B24" ref-type="bibr">24</xref>), mediating prefrontal cortex and thalamo-cortical pathways (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B28" ref-type="bibr">28</xref>). Eventually, these common neurobiological aspects may explain the occurrence of memory/attention deficits and headache disorder.</p><p>In conclusion, the results of this study revealed that migraine and TTH may have an impact on both non-verbal memory and attention skills in children and adolescents. The findings confirm the importance of a cognitive assessment in these patients, especially regarding memory and attention skills, also for the impact of these abilities on academic performances. Moreover, any possible cognitive impairment, along with the severity of the disease, should be considered in anticipation of any prophylactic pharmacological therapy.</p><p>However, the small size of the sample was a limitation of this study; eventually, further studies with larger samples could better define the relationship between headache and its impact on non-verbal cognitive abilities. Moreover, it would be interesting to follow the evolution of these aspects over time, in order to evaluate how much they can affect the prognosis of the primary headache with an onset during developmental age if compared to the disorder with an onset during adulthood.</p></sec><sec id="S5"><title>Ethics Statement</title><p>For this study, an ethical review process by the Local Ethics Committee of Azienda Ospedaliero-Universitaria Policlinico di Bari (Italy) was not required, since all the procedures within the study assessment are included in the headache diagnostic protocol of our Child and Adolescence Neuropsychiatry Unit. All the participants were recruited after obtaining a written informed consent by their parents.</p></sec><sec id="S6"><title>Author Contributions</title><p>LM, MB, and PL contributed to the conception, the design, the supervision, and the final approval of the work. RP, MS, MM, and SS contributed to the enrollment of the participants, to the general and cognitive assessment and to data collection. FC performed the statistical analysis. All authors reviewed and edited the manuscript.</p></sec><sec id="S7"><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ref-list><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maffioletti</surname><given-names>E</given-names></name><name><surname>Ferro</surname><given-names>F</given-names></name><name><surname>Pucci</surname><given-names>E</given-names></name><name><surname>Persico</surname><given-names>MG</given-names></name><name><surname>Molteni</surname><given-names>S</given-names></name><name><surname>Nappi</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>P035. Headache prevalence and disability among Italian adolescents aged 11&#x02013;15 years: a population cross-sectional study</article-title>. <source>J Headache Pain</source> (<year>2015</year>) <volume>16</volume>(<issue>Suppl 1</issue>):<fpage>A148</fpage>
<pub-id pub-id-type="doi">10.1186/1129-2377-16-S1-A148</pub-id><pub-id pub-id-type="pmid">28132240</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>W&#x000f6;ber-Bing&#x000f6;l</surname><given-names>C</given-names></name></person-group>. <article-title>Epidemiology of migraine and headache in children and adolescents</article-title>. <source>Curr Pain Headache Rep</source> (<year>2013</year>) <volume>17</volume>(<issue>6</issue>):<fpage>341</fpage>. <pub-id pub-id-type="doi">10.1007/s11916-013-0341-z</pub-id><?supplied-pmid 23700075?><pub-id pub-id-type="pmid">23700075</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abu-Arafeh</surname><given-names>I</given-names></name><name><surname>Razak</surname><given-names>S</given-names></name><name><surname>Sivaraman</surname><given-names>B</given-names></name><name><surname>Graham</surname><given-names>C</given-names></name></person-group>
<article-title>The prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies</article-title>. <source>Dev Med Child Neurol</source> (<year>2010</year>) <volume>52</volume>(<issue>12</issue>):<fpage>1088</fpage>&#x02013;<lpage>97</lpage>.<pub-id pub-id-type="doi">10.1111/j.1469-8749.2010.03793.x</pub-id><pub-id pub-id-type="pmid">20875042</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langdon</surname><given-names>R</given-names></name><name><surname>DiSabella</surname><given-names>MT</given-names></name></person-group>. <article-title>Pediatric headache: an overview</article-title>. <source>Curr Probl Pediatr Adolesc Health Care</source> (<year>2017</year>) <volume>47</volume>(<issue>3</issue>):<fpage>44</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="doi">10.1016/j.cppeds.2017.01.002</pub-id><?supplied-pmid 28366491?><pub-id pub-id-type="pmid">28366491</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calandre</surname><given-names>EP</given-names></name><name><surname>Bembibre</surname><given-names>J</given-names></name><name><surname>Arnedo</surname><given-names>ML</given-names></name><name><surname>Becerra</surname><given-names>D</given-names></name></person-group>. <article-title>Cognitive disturbances and regional cerebral blood flow abnormalities in migraine patients: their relationship with the clinical manifestations of the illness</article-title>. <source>Cephalalgia</source> (<year>2002</year>) <volume>22</volume>(<issue>4</issue>):<fpage>291</fpage>&#x02013;<lpage>302</lpage>.<pub-id pub-id-type="doi">10.1046/j.1468-2982.2002.00370.x</pub-id><?supplied-pmid 12100092?><pub-id pub-id-type="pmid">12100092</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Pira</surname><given-names>F</given-names></name><name><surname>Zappal&#x000e0;</surname><given-names>G</given-names></name><name><surname>Giuffrida</surname><given-names>S</given-names></name><name><surname>Lo Bartolo</surname><given-names>ML</given-names></name><name><surname>Reggio</surname><given-names>E</given-names></name><name><surname>Morana</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Memory disturbances in migraine with and without aura: a strategy problem?</article-title>
<source>Cephalalgia</source> (<year>2000</year>) <volume>20</volume>(<issue>5</issue>):<fpage>475</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1046/j.1468-2982.2000.00074.x</pub-id><?supplied-pmid 11037744?><pub-id pub-id-type="pmid">11037744</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulder</surname><given-names>EJCM</given-names></name><name><surname>Linssen</surname><given-names>WHJP</given-names></name><name><surname>Passchier</surname><given-names>J</given-names></name><name><surname>Orlebeke</surname><given-names>JF</given-names></name><name><surname>de Geus</surname><given-names>EJC</given-names></name></person-group>. <article-title>Interictal and postictal cognitive changes in migraine</article-title>. <source>Cephalalgia</source> (<year>1999</year>) <volume>19</volume>:<fpage>557</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="doi">10.1046/j.1468-2982.1999.019006557.x</pub-id><?supplied-pmid 10448542?><pub-id pub-id-type="pmid">10448542</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villa</surname><given-names>TR</given-names></name><name><surname>Correa</surname><given-names>Moutran AR</given-names></name><name><surname>Sobirai</surname><given-names>Diaz LA</given-names></name><name><surname>Pereira</surname><given-names>Pinto MM</given-names></name><name><surname>Carvalho</surname><given-names>FA</given-names></name><name><surname>Gabbai</surname><given-names>AA</given-names></name><etal/></person-group>
<article-title>Visual attention in children with migraine: a controlled comparative study</article-title>. <source>Cephalalgia</source> (<year>2009</year>) <volume>29</volume>(<issue>6</issue>):<fpage>631</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1111/j.1468-2982.2008.01767</pub-id><?supplied-pmid 19187339?><pub-id pub-id-type="pmid">19187339</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x02019;Andrea</surname><given-names>G</given-names></name><name><surname>Nertempi</surname><given-names>P</given-names></name><name><surname>Ferro</surname><given-names>Milone F</given-names></name><name><surname>Joseph</surname><given-names>R</given-names></name><name><surname>Cananzi</surname><given-names>JR</given-names></name></person-group>. <article-title>Personality and memory in childhood migraine</article-title>. <source>Cephalalgia</source> (<year>1989</year>) <volume>9</volume>:<fpage>25</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1046/j.1468-2982.1989.901025.x</pub-id><?supplied-pmid 2706672?><pub-id pub-id-type="pmid">2706672</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riva</surname><given-names>D</given-names></name><name><surname>Aggio</surname><given-names>F</given-names></name><name><surname>Vago</surname><given-names>C</given-names></name><name><surname>Nichelli</surname><given-names>F</given-names></name><name><surname>Andreucci</surname><given-names>E</given-names></name><name><surname>Paruta</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Cognitive and behavioural effects of migraine in childhood and adolescence</article-title>. <source>Cephalalgia</source> (<year>2006</year>) <volume>26</volume>:<fpage>596</fpage>&#x02013;<lpage>603</lpage>.<pub-id pub-id-type="doi">10.1111/j.1468-2982.2006.01072.x</pub-id><?supplied-pmid 16674769?><pub-id pub-id-type="pmid">16674769</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parisi</surname><given-names>P</given-names></name><name><surname>Verrotti</surname><given-names>A</given-names></name><name><surname>Paolino</surname><given-names>MC</given-names></name><name><surname>Urbano</surname><given-names>A</given-names></name><name><surname>Bernabucci</surname><given-names>M</given-names></name><name><surname>Castaldo</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Headache and cognitive profile in children: a cross-sectional controlled study</article-title>. <source>J Headache Pain</source> (<year>2010</year>) <volume>11</volume>:<fpage>45</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1007/s10194-009-0165-8</pub-id><?supplied-pmid 19841863?><pub-id pub-id-type="pmid">19841863</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moutran</surname><given-names>AR</given-names></name><name><surname>Villa</surname><given-names>TR</given-names></name><name><surname>Diaz</surname><given-names>LA</given-names></name><name><surname>Noffs</surname><given-names>MH</given-names></name><name><surname>Pinto</surname><given-names>MM</given-names></name><name><surname>Gabbai</surname><given-names>AA</given-names></name><etal/></person-group>
<article-title>Migraine and cognition in children: a controlled study</article-title>. <source>Arq Neuropsiquiatr</source> (<year>2011</year>) <volume>69</volume>(<issue>2A</issue>):<fpage>192</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1590/S0004-282X2011000200010</pub-id><?supplied-pmid 21537559?><pub-id pub-id-type="pmid">21537559</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esposito</surname><given-names>M</given-names></name><name><surname>Pascotto</surname><given-names>A</given-names></name><name><surname>Gallai</surname><given-names>B</given-names></name><name><surname>Parisi</surname><given-names>L</given-names></name><name><surname>Roccella</surname><given-names>M</given-names></name><name><surname>Marotta</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Can headache impair intellectual abilities in children? An observational study</article-title>. <source>Neuropsychiatr Dis Treat</source> (<year>2012</year>) <volume>8</volume>:<fpage>509</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="doi">10.2147/NDT.S36863</pub-id><?supplied-pmid 23139628?><pub-id pub-id-type="pmid">23139628</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hershey</surname><given-names>AD</given-names></name><name><surname>Powers</surname><given-names>SW</given-names></name><name><surname>Vockell</surname><given-names>AL</given-names></name><name><surname>LeCates</surname><given-names>S</given-names></name><name><surname>Kabbouche</surname><given-names>MA</given-names></name><name><surname>Maynard</surname><given-names>MK</given-names></name></person-group>. <article-title>PedMIDAS: development of a questionnaire to assess disability of migraines in children</article-title>. <source>Neurology</source> (<year>2001</year>) <volume>57</volume>:<fpage>2034</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1212/WNL.57.11.2034</pub-id><?supplied-pmid 11739822?><pub-id pub-id-type="pmid">11739822</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cornoldi</surname><given-names>C</given-names></name><name><surname>Giofr&#x000e8;</surname><given-names>D</given-names></name><name><surname>Belacchi</surname><given-names>C</given-names></name></person-group>
<article-title>Procedure di somministrazione e scoring dei subtest</article-title>. In: <person-group person-group-type="editor"><name><surname>di Roid</surname><given-names>GH</given-names></name><name><surname>Miller</surname><given-names>LJ</given-names></name><name><surname>Pomplun</surname><given-names>M</given-names></name><name><surname>Koch</surname><given-names>C</given-names></name></person-group>, editors. <source>Leiter-3 Leiter International Scale-Thirth Edition</source>. <publisher-loc>Firenze</publisher-loc>: <publisher-name>Giunti O.S. Organizzazioni Speciali s.r.l.</publisher-name>
<italic>Adattamento italiano</italic> (<year>2016</year>). p. <fpage>23</fpage>&#x02013;<lpage>85</lpage>.</mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haverkamp</surname><given-names>F</given-names></name><name><surname>H&#x000f6;nscheid</surname><given-names>A</given-names></name><name><surname>M&#x000fc;ller-Sinik</surname><given-names>DP</given-names></name></person-group>. <article-title>Cognitive development in children with migraine and their healthy unaffected siblings</article-title>. <source>Headache</source> (<year>2002</year>) <volume>42</volume>(<issue>8</issue>):<fpage>776</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1046/j.1526-4610.2002.02179.x</pub-id><?supplied-pmid 12390640?><pub-id pub-id-type="pmid">12390640</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beard</surname><given-names>RM</given-names></name></person-group>
<article-title>The structure of perception: a factorial study</article-title>. <source>Br J Educ Psychol</source> (<year>1965</year>) <volume>35</volume>:<fpage>210</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="doi">10.1111/j.2044-8279.1965.tb01805.x</pub-id><pub-id pub-id-type="pmid">14320839</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Talland</surname><given-names>GA</given-names></name></person-group>
<source>Deranged Memory</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Academic Press</publisher-name> (<year>1965</year>).</mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cools</surname><given-names>R</given-names></name><name><surname>Gibbs</surname><given-names>SE</given-names></name><name><surname>Miyakawa</surname><given-names>A</given-names></name><name><surname>Jagust</surname><given-names>W</given-names></name><name><surname>D&#x02019;Esposito</surname><given-names>M</given-names></name></person-group>. <article-title>Working memory capacity predicts dopamine synthesis capacity in the human striatum</article-title>. <source>J Neurosci</source> (<year>2008</year>) <volume>28</volume>(<issue>5</issue>):<fpage>1208</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4475-07.2008</pub-id><?supplied-pmid 18234898?><pub-id pub-id-type="pmid">18234898</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aalto</surname><given-names>S</given-names></name><name><surname>Br&#x000fc;ck</surname><given-names>A</given-names></name><name><surname>Laine</surname><given-names>M</given-names></name><name><surname>N&#x000e5;gren</surname><given-names>K</given-names></name><name><surname>Rinne</surname><given-names>JO</given-names></name></person-group>. <article-title>Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457</article-title>. <source>J Neurosci</source> (<year>2005</year>) <volume>25</volume>(<issue>10</issue>):<fpage>2471</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2097-04.2005</pub-id><?supplied-pmid 15758155?><pub-id pub-id-type="pmid">15758155</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nieoullon</surname><given-names>A</given-names></name></person-group>. <article-title>Dopamine and the regulation of cognition and attention</article-title>. <source>Prog Neurobiol</source> (<year>2002</year>) <volume>67</volume>(<issue>1</issue>):<fpage>53</fpage>&#x02013;<lpage>83</lpage>.<pub-id pub-id-type="doi">10.1016/S0301-0082(02)00011-4</pub-id><?supplied-pmid 12126656?><pub-id pub-id-type="pmid">12126656</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goadsby</surname><given-names>PJ</given-names></name><name><surname>Lipton</surname><given-names>RB</given-names></name><name><surname>Ferrari</surname><given-names>MD</given-names></name></person-group>
<article-title>Migraine current understanding and treatment</article-title>. <source>N Engl J Med</source> (<year>2002</year>) <volume>346</volume>(<issue>4</issue>):<fpage>257</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1056/NEJMra010917</pub-id><pub-id pub-id-type="pmid">11807151</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akerman</surname><given-names>S</given-names></name><name><surname>Goadsby</surname><given-names>PJ</given-names></name></person-group>. <article-title>Dopamine and migraine: biology and clinical implications</article-title>. <source>Cephalalgia</source> (<year>2007</year>) <volume>27</volume>(<issue>11</issue>):<fpage>1308</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="doi">10.1111/j.1468-2982.2007.01478.x</pub-id><?supplied-pmid 17970991?><pub-id pub-id-type="pmid">17970991</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergerot</surname><given-names>A</given-names></name><name><surname>Storer</surname><given-names>RJ</given-names></name><name><surname>Goadsby</surname><given-names>PJ</given-names></name></person-group>. <article-title>Dopamine inhibits trigeminovascular transmission in the rat</article-title>. <source>Ann Neurol</source> (<year>2007</year>) <volume>61</volume>(<issue>3</issue>):<fpage>251</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1002/ana.21077</pub-id><?supplied-pmid 17387726?><pub-id pub-id-type="pmid">17387726</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fanciullacci</surname><given-names>M</given-names></name><name><surname>Alessandri</surname><given-names>M</given-names></name><name><surname>Del</surname><given-names>Rosso A</given-names></name></person-group>. <article-title>Dopamine involvement in the migraine attack</article-title>. <source>Funct Neurol</source> (<year>2000</year>) <volume>15</volume>(<issue>Suppl 3</issue>):<fpage>171</fpage>&#x02013;<lpage>81</lpage>.<?supplied-pmid 11200788?><pub-id pub-id-type="pmid">11200788</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsutani</surname><given-names>K</given-names></name><name><surname>Tsuruoka</surname><given-names>M</given-names></name><name><surname>Shinya</surname><given-names>A</given-names></name><name><surname>Furuya</surname><given-names>R</given-names></name><name><surname>Kawawa</surname><given-names>T</given-names></name></person-group>. <article-title>Stimulation of the locus coeruleus suppresses trigeminal sensorimotor function in the rat</article-title>. <source>Brain Res Bull</source> (<year>2000</year>) <volume>53</volume>(<issue>6</issue>):<fpage>827</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1016/S0361-9230(00)00426-3</pub-id><?supplied-pmid 11179850?><pub-id pub-id-type="pmid">11179850</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coull</surname><given-names>JT</given-names></name></person-group>. <article-title>Neural correlates of attention and arousal: insights from electrophysiology, functional neuroimaging and psychopharmacology</article-title>. <source>Prog Neurobiol</source> (<year>1998</year>) <volume>55</volume>(<issue>4</issue>):<fpage>343</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1016/S0301-0082(98)00011-2</pub-id><?supplied-pmid 9654384?><pub-id pub-id-type="pmid">9654384</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noseda</surname><given-names>R</given-names></name><name><surname>Borsook</surname><given-names>D</given-names></name><name><surname>Burstein</surname><given-names>R</given-names></name></person-group>. <article-title>Neuropeptides and neurotransmitters that modulate thalamo-cortical pathways relevant to migraine headache</article-title>. <source>Headache</source> (<year>2017</year>) <volume>57</volume>(<issue>Suppl 2</issue>):<fpage>97</fpage>&#x02013;<lpage>111</lpage>.<pub-id pub-id-type="doi">10.1111/head.13083</pub-id><?supplied-pmid 28485844?><pub-id pub-id-type="pmid">28485844</pub-id></mixed-citation></ref></ref-list></back></article>